Henan Lingrui Pharmaceutical Co Ltd

600285 • SHG

¥19.28-¥0.15 (0.77%)

Estimate

P/E

14.1

EPS

1.37

Beta

-0.029

Growth

Revenue, YoY

-5.24%

Net income, YoY

-3.42%

FCF, YoY

104.31%

Forecast

P/E (FWD)

12.9

EPS (FWD)

1.5

Dividends

Dividend yield

5.71%

Annual payout

¥1.10

Next ex. div date

June 11, 27

Payout

145.51%

Div.growth, 5y

24.57%

Dividend growth streak

7 y

Div.rating

About the company

Ticker

600285

ISIN

CNE000001501

Country

China

Sector (GICS)

Healthcare

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Medical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, nutritional supplements, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules. The company also engages in industrial and real estate investment; technology research and development; ecological agriculture; and high-tech activities. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is headquartered in Xinyang, China.

Frequently asked questions

What sector does Henan Lingrui Pharmaceutical Co Ltd (600285) operate in?

Henan Lingrui Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Henan Lingrui Pharmaceutical Co Ltd (600285) current stock price?

As of the latest data, Henan Lingrui Pharmaceutical Co Ltd stock price is CN¥19.28, with a previous close of CN¥19.43. Henan Lingrui Pharmaceutical Co Ltd lost -CN¥0.15 in the last trading session, representing a -0.77% loss.

What is Henan Lingrui Pharmaceutical Co Ltd (600285) current market capitalization?

Henan Lingrui Pharmaceutical Co Ltd market cap is approximately 10.93 billion.

What is Henan Lingrui Pharmaceutical Co Ltd (600285) Earnings Per Share (EPS)?

The trailing EPS is CN¥1.37, and the forward EPS is CN¥1.50.

What is Henan Lingrui Pharmaceutical Co Ltd (600285) Price-to-Earnings (P/E) ratio?

Henan Lingrui Pharmaceutical Co Ltd current P/E ratio is 14.07, with a forward P/E of 12.85.

Does Henan Lingrui Pharmaceutical Co Ltd (600285) pay dividends?

Yes. Henan Lingrui Pharmaceutical Co Ltd pays annual dividends with an annualized yield of 5.71% and an estimated annual payout of CN¥1.10 per share.

When is the next ex-dividend date for Henan Lingrui Pharmaceutical Co Ltd (600285)?

The next ex-dividend date is scheduled for June 11, 2027.

What is Henan Lingrui Pharmaceutical Co Ltd (600285) beta (volatility) score?

Henan Lingrui Pharmaceutical Co Ltd has a beta of -0.029, indicating lower volatility than the overall market.